Australien - engelska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - glutamic acid; glycine; soya oil; tryptophan; potassium chloride; phenylalanine; sodium glycerophosphate; proline; aspartic acid; leucine; magnesium sulfate; serine; lysine hydrochloride; methionine; tyrosine; valine; threonine; arginine; histidine; isoleucine; calcium chloride; sodium acetate; glucose; alanine -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - serine; calcium chloride; valine; sodium acetate; soya oil; magnesium sulfate; proline; sodium glycerophosphate; tyrosine; potassium chloride; tryptophan; threonine; phenylalanine; glycine; alanine; isoleucine; arginine; lysine hydrochloride; histidine; glutamic acid; leucine; glucose; methionine; aspartic acid -

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.91 mg/ml;  ; ergocalciferol 0.5 µg/ml; phytomenadione 15 µg/ml; retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.91 mg/ml   ergocalciferol 0.5 µg/ml phytomenadione 15 µg/ml retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.64 mg/ml;  ; ergocalciferol 1 µg/ml; phytomenadione 20 µg/ml; retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.64 mg/ml   ergocalciferol 1 µg/ml phytomenadione 20 µg/ml retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n infant is indicated in paediatric patients up to 11 years of age as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - moxifloxacin hydrochloride 1.75 mg/ml equivalent to moxifloxacin 1.6mg/ml;   - solution for infusion - active: moxifloxacin hydrochloride 1.75 mg/ml equivalent to moxifloxacin 1.6mg/ml   excipient: sodium acetate trihydrate sodium sulfate sulfuric acid water for injection - indicated for the treatment of the following bacterial infections caused by susceptible strains: - pneumonia (community acquired)

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; calcium gluconate monohydrate 2.24 g/l;  ; cysteine 0.42 g/l (as l-cysteine hydrochloride); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ; histidine 5.1 g/l (l-histidine);  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine hydrochloride 6.8 g/l;  ;  ;  ; magnesium sulfate heptahydrate 1.97 g/l; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; potassium chloride 3.73 g/l; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; sodium acetate trihydrate 13.6 g/l;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     calcium gluconate monohydrate 2.24 g/l   cysteine 0.42 g/l (as l-cysteine hydrochloride) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)     histidine 5.1 g/l (l-histidine)     isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine hydrochloride 6.8 g/l       magnesium sulfate heptahydrate 1.97 g/l methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       potassium chloride 3.73 g/l proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         sodium acetate trihydrate 13.6 g/l     threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)     excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; cysteine 0.42 g/l (l-cysteine); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 5.1 g/l (l-histidine);  ;  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l;  ;  ; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     cysteine 0.42 g/l (l-cysteine) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)       histidine 5.1 g/l (l-histidine)       isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l     methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 16 g/l;  ;  ;  ; arginine 11.3 g/l (l-arginine);  ;  ; aspartic acid 3.4 g/l (l-aspartic acid);  ;  ; cysteine 560 mg/l (l-cysteine); glutamic acid 5.6 g/l (l-glutamic acid);  ;  ; glycine 7.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 6.8 g/l (l-histidine);  ;  ;  ; isoleucine 5.6 g/l (l-isoleucine);  ;  ;  ; leucine 7.9 g/l (l-leucine);  ;  ;  ; lysine acetate 12.7 g/l equivalent to 6 g/l lysine a;  ;  ; methionine 5.6 g/l (l-methionine);  ;  ; phenylalanine 7.9 g/l (l-phenylalanine);  ;  ;  ; proline 6.8 g/l (l-proline);  ; serine 4.5 g/l (l-serine);  ;  ;  ;  ; threonine 5.6 g/l (l-threonine);  ;  ;  ; tryptophan 1.9 g/l (l-tryptophan);  ; tyrosine 230 mg/l (l-tyrosine); valine 7.3 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 16 g/l       arginine 11.3 g/l (l-arginine)     aspartic acid 3.4 g/l (l-aspartic acid)     cysteine 560 mg/l (l-cysteine) glutamic acid 5.6 g/l (l-glutamic acid)     glycine 7.9 g/l (as aminoacetic acid)       histidine 6.8 g/l (l-histidine)       isoleucine 5.6 g/l (l-isoleucine)       leucine 7.9 g/l (l-leucine)       lysine acetate 12.7 g/l equivalent to 6 g/l lysine a     methionine 5.6 g/l (l-methionine)     phenylalanine 7.9 g/l (l-phenylalanine)       proline 6.8 g/l (l-proline)   serine 4.5 g/l (l-serine)         threonine 5.6 g/l (l-threonine)       tryptophan 1.9 g/l (l-tryptophan)   tyrosine 230 mg/l (l-tyrosine) valine 7.3 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is need to control the total amount of fluid being given to a patient. vamin 18 has been shown to reduce nitrogen loss in patients with major burns without sepsis.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - macrogol 3350 755.68 mg/g (prepared solution contains 6% w/w); potassium chloride 10.55 mg/g; sodium chloride 37.33 mg/g; sodium sulfate 80.62 mg/g - powder for oral solution - 6% w/w - active: macrogol 3350 755.68 mg/g (prepared solution contains 6% w/w) potassium chloride 10.55 mg/g sodium chloride 37.33 mg/g sodium sulfate 80.62 mg/g excipient: ascorbic acid aspartame citric acid lemon flavour ql58817 - glycoprep-c is indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination (such as colonoscopy, barium enema x-ray examination), prior to intravenous pyelograms (ivp) or colonic surgery.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - citric acid 12.77 mg/g; macrogol 3350 755.68 mg/g (as macrogol 3350 prepared solution contains 6% w/w); potassium chloride 10.55 mg/g; sodium chloride 37.33 mg/g;  ; sodium sulfate 80.62 mg/g; citric acid 771.868 mg/g; heavy magnesium oxide 225.128 mg/g; sodium picosulfate 0.64 mg/g - combination - active: citric acid 12.77 mg/g macrogol 3350 755.68 mg/g (as macrogol 3350 prepared solution contains 6% w/w) potassium chloride 10.55 mg/g sodium chloride 37.33 mg/g   sodium sulfate 80.62 mg/g excipient: ascorbic acid aspartame lemon flavour ql58817 active: citric acid 771.868 mg/g heavy magnesium oxide 225.128 mg/g sodium picosulfate 0.64 mg/g excipient: aspartame - indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination